Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route
Hadel A. Abo El-Enin, Mohammed H. Elkomy, Ibrahim A. Naguib, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 281-281
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Chitosan on the surface of nanoparticles for enhanced drug delivery: A comprehensive review
Mohammed H. Elkomy, Adel A. Ali, Hussein M. Eid
Journal of Controlled Release (2022) Vol. 351, pp. 923-940
Closed Access | Times Cited: 85
Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
P. Mura, Francesca Maestrelli, Marzia Cirri, et al.
Marine Drugs (2022) Vol. 20, Iss. 5, pp. 335-335
Open Access | Times Cited: 84
Surface-Modified Bilosomes Nanogel Bearing a Natural Plant Alkaloid for Safe Management of Rheumatoid Arthritis Inflammation
Mohammed H. Elkomy, Nabil K. Alruwaili, Mohammed Elmowafy, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 563-563
Open Access | Times Cited: 54
Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends
Tapan Behl, Sukhbir Singh, Neelam Sharma, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3705-3705
Open Access | Times Cited: 49
Nose to brain delivery of donepezil through surface modified NLCs: Formulation development, optimization, and brain targeting study
Mohd Yasir, Ameeduzzafar Zafar, K.M. Noorulla, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103631-103631
Closed Access | Times Cited: 47
Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
Erjie Tian, Gaurav Sharma, Chongshan Dai
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1883-1883
Open Access | Times Cited: 33
Recent Progress of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Ocular Drug Delivery Platforms
Viliana Gugleva, Velichka Andonova
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 474-474
Open Access | Times Cited: 29
Intranasal Drug Administration in Alzheimer-Type Dementia: Towards Clinical Applications
Raquel Taléns‐Visconti, Jesús Vicente de Julián-Ortiz, Ofelia Vila-Busó, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1399-1399
Open Access | Times Cited: 27
Potential of Lipid-Based Nanocarriers against Two Major Barriers to Drug Delivery—Skin and Blood–Brain Barrier
Mohammad Sameer Khan, Sradhanjali Mohapatra, Vaibhav Gupta, et al.
Membranes (2023) Vol. 13, Iss. 3, pp. 343-343
Open Access | Times Cited: 25
Chitosan Nanoparticles for Intranasal Drug Delivery
Hossein Omidian, Erma J. Gill, Sumana Dey Chowdhury, et al.
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 746-746
Open Access | Times Cited: 9
Research progress on pharmacological effects and bioavailability of berberine
Yulong Cui, Quanying Zhou, Min Jin, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8485-8514
Closed Access | Times Cited: 8
Chitosan-coated nanostructured lipid carriers for intranasal delivery of sinapic acid in Aβ1–42 induced C57BL/6 mice for Alzheimer's disease treatment
A Prabakaran, Debarati Rakshit, Inklisan Patel, et al.
International Journal of Biological Macromolecules (2025), pp. 141136-141136
Closed Access | Times Cited: 1
Formulation of intranasal surface engineered nanostructured lipid carriers of rotigotine: Full factorial design optimization, in vitro characterization, and pharmacokinetic evaluation
Ameeduzzafar Zafar, Omar Awad Alsaidan, Nabil K. Alruwaili, et al.
International Journal of Pharmaceutics (2022) Vol. 627, pp. 122232-122232
Closed Access | Times Cited: 36
Intranasal Delivery of Granisetron to the Brain via Nanostructured Cubosomes-Based In Situ Gel for Improved Management of Chemotherapy-Induced Emesis
Dalia Essam Eissa, Mohammed H. Elkomy, Hussein M. Eid, et al.
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1374-1374
Open Access | Times Cited: 31
Mucus-Penetrating Alginate-Chitosan Nanoparticles Loaded with Berberine Hydrochloride for Oral Delivery to the Inflammation Site of Ulcerative Colitis
Lingfeng Sun, Xiangjiang Nie, Wenjie Lu, et al.
AAPS PharmSciTech (2022) Vol. 23, Iss. 6
Closed Access | Times Cited: 30
Dietary phytochemicals: As a potential natural source for treatment of Alzheimer's Disease
Renying Zhuo, Haixia Yang, Chenhui Zhu, et al.
Food Innovation and Advances (2023) Vol. 2, Iss. 1, pp. 36-43
Open Access | Times Cited: 18
Unraveling the role of chitosan for nasal drug delivery systems: A review
Gurjeet Kaur, Jayant Goyal, Prabhat Kumar Behera, et al.
Carbohydrate Polymer Technologies and Applications (2023) Vol. 5, pp. 100316-100316
Open Access | Times Cited: 17
Nose-to-Brain Targeted Delivery of Donepezil Hydrochloride via Novel Hyaluronic Acid-Doped Nanotransfersomes for Alzheimer's Disease Mitigation
Heba F. Salem, Heba M. Aboud, Mostafa M. Abdellatif, et al.
Journal of Pharmaceutical Sciences (2024)
Closed Access | Times Cited: 7
A Novel Chitosan-coated Leciplex Loaded with Ambrisentan as a Possible Pulmonary Nanosystem: Optimization, Characterization, and Pharmacokinetics Assessments
Hussein M. Eid, Toqa H. Turkia, Adel A. Ali, et al.
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2320-2330
Closed Access | Times Cited: 7
Verapamil-Loaded Cubosomes for Enhancing Intranasal Drug Delivery: Development, Characterization, Ex Vivo Permeation, and Brain Biodistribution Studies
Mennatullah M. Faisal, Eman Gomaa, Adel Ehab Ibrahim, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 5
Open Access | Times Cited: 6
Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats
Mohammed H. Elkomy, Hussein M. Eid, Mohammed Elmowafy, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 2694-2704
Open Access | Times Cited: 27
Development of surface modified bilosomes for the oral delivery of quercetin: optimization, characterization in-vitro antioxidant, antimicrobial, and cytotoxicity study
Nabil K. Alruwaili, Ameeduzzafar Zafar, Omar Awad Alsaidan, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 3035-3050
Open Access | Times Cited: 25
Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies
Mohammed H. Elkomy, Randa Mohammed Zaki, Omar Awad Alsaidan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 7, pp. 1805-1805
Open Access | Times Cited: 14
Novel nasal niosomes loaded with lacosamide and coated with chitosan: A possible pathway to target the brain to control partial-onset seizures
Alaa S. Tulbah, Mohammed H. Elkomy, Randa Mohammed Zaki, et al.
International Journal of Pharmaceutics X (2023) Vol. 6, pp. 100206-100206
Open Access | Times Cited: 13
Elucidating Berberine’s Therapeutic and Photosensitizer Potential through Nanomedicine Tools
Célia Marques, Maria Helena Fernandes, Sofia A. Costa Lima
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2282-2282
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top